Impressive Financial Performance

GE HealthCare Technologies Inc. has announced a notable 2.1% increase in its fourth-quarter revenue for the fiscal year 2024, totaling $5.3 billion. This growth reflects the company's strong performance and resilience in a competitive market.

Net Income and EPS Soar

The company's net income and diluted earnings per share (EPS) experienced a significant surge, with both metrics climbing 78% year-on-year to $720 million and $1.57, respectively. This remarkable achievement underscores GE HealthCare's effective strategies and operational efficiency.

Annual Growth and Future Outlook

For the entire fiscal year 2024, GE HealthCare reported a 0.6% increase in total revenues, reaching $19.7 billion. Net income rose by 27% to $1.9 billion, and diluted EPS saw a 43% increase to $4.34. Looking ahead, the company forecasts an adjusted EPS between $4.61 and $4.75 for 2025, signaling confidence in its continued growth trajectory.

Leadership's Perspective

"The strong momentum in orders, backlog, and book-to-bill observed in the fourth quarter is a testament to our team's dedication and the trust our customers place in us," stated Peter Arduini, President and CEO of GE HealthCare. Despite a slight 1.05% drop in share price during premarket trading, the company remains optimistic about its future prospects.